Shares of Clover Health Corp. (NASDAQ: CLOV) surged by nearly 6% on Thursday, propelled by positive developments related to its Medicare Advantage plans and benchmark rates from the Centers for Medicare & Medicaid Services (CMS).
For the 2025 plan year, CMS awarded Clover Health's Medicare Advantage PPO plans a coveted 4-star quality rating, while its HMO plans received a respectable 3.5-star rating. These high ratings are expected to significantly boost Clover Health's competitiveness and ability to attract and retain Medicare Advantage enrollees, a key driver of growth for the company.
Furthermore, Clover Health announced that its 4-star rating for its PPO contract will lead to a general 5% increase in benchmark payment rates for the 2026 plan year. This increase in benchmark rates, which are used to determine Medicare Advantage plan reimbursements from CMS, is expected to directly translate into higher revenues for the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.